Site-selective bioconjugation to native protein residues is a powerful tool for protein functionalization, with cysteine and lysine side chains being the most common points for attachment owing to their high nucleophilicity. We now report a strategy for histidine modification using thiophosphorodichloridate reagents that mimic post-translational histidine phosphorylation, enabling fast and selective labeling of protein histidines under mild conditions where various payloads can be introduced via copper-assisted alkyne-azide cycloaddition (CuAAC) chemistry. We establish that these reagents are particularly effective at covalent modification of His-tags, which are common motifs to facilitate protein purification, as illustrated by selective attachment of polyarginine cargoes to enhance the uptake of proteins into living cells. This work provides a starting point for probing and enhancing protein function using histidine-directed chemistry. ABSTRACT: Site-selective bioconjugation to native protein residues is a powerful tool for protein functionalization, with cysteine and lysine side chains being the most common points for attachment owing to their high nucleophilicity. We now report a strategy for histidine modification using thiophosphorodichloridate reagents that mimic post-translational histidine phosphorylation, enabling fast and selective labeling of protein histidines under mild conditions where various payloads can be introduced via copperassisted alkyne-azide cycloaddition (CuAAC) chemistry. We establish that these reagents are particularly effective at covalent modification of His-tags, which are common motifs to facilitate protein purification, as illustrated by selective attachment of polyarginine cargoes to enhance the uptake of proteins into living cells. This work provides a starting point for probing and enhancing protein function using histidine-directed chemistry.
INTRODUCTION
Site-selective bioconjugation chemistry offers a versatile strategy to probe and expand the function of proteins. [1] [2] [3] [4] [5] The most common and robust chemoselective and regioselective protein bioconjugation strategies have focused on functionalization of cysteine thiol [6] [7] [8] [9] and lysine amine [10] [11] [12] sites and related nucleophilic hydroxyl 13, 14 and carboxyl 15 side chains. More recent advances in protein bioconjugation technologies have targeted access to less nucleophlic amino acids, 16 including tyrosine, [17] [18] [19] tryptophan 20, 21 and methionine. 22 In contrast, selective modification of histidine, which is commonly found in enzyme active sites and metal-binding sites, 23, 24 remains underexplored. Because the imidazole side chain of histidine is a good metal ligand, metal coordination can enable protein modification through metal-directed covalent labeling proximal to the histidine group 25, 26 or direct non-covalent metalhistidine complexation, [27] [28] [29] [30] [31] the latter of which can be labile under biological contexts or mass spectrometry conditions. On the other hand, histidine is a useful catalytic component owing to its ability to serve as both a good nucleophile and leaving group, but this character also makes it difficult to form stable bonds with the imidazole side chain through electrophilic functionalization. Indeed, selected epoxides are histidinereactive but typically require harsh reaction conditions such as high temperatures and/or strong bases 32, 33 or an affinitydirected ligand. 34, 35 As such, selective and direct covalent labeling of histidine remains a challenge.
RESULTS AND DISCUSSION
Design and synthesis. Inspired by observations of reversible histidine phosphorylation as an emerging post-translational modification in prokaryotes and eukaryotes and elegant studies to probe its biological functions, [36] [37] [38] [39] we sought to develop a histidine-selective bioconjugation method that mimics this type of chemistry ( Figure 1a ). We turned our attention to phosphorus-based electrophiles, based on precedent that potassium phosphoramidate can selectively phosphorylate histidine 40, 41 and that thiophosphoryl chloride and potassium thiophosphoramidate can generate thiophosphohistidine analogs with improved aqueous stability. [42] [43] [44] To this end, we synthesized a series of phosphorus electrophiles with varying reactivity as suggested by their different synthesis and handling methods (Scheme 1). We first tested thiophosphoramidate 1 combining a phosphosulfide moiety for histidine labeling and an alkyne group for further functionalization, but this compound did not show an observable reaction with Fmoc-His-OH in buffered aqueous solution (Scheme 2). We then tested compound 2, where we hypothesized that installation of chloride as a better leaving group might enhance reactivity. Indeed, thiophosphochloride 2 did show appreciable labeling of FmocHis-OH, but the resulting product underwent significant hydrolysis back to the unmodified histidine over prolonged Scheme 1 Different routes for synthesis of phosphorus electrophiles.
Scheme 2 Reaction yields of phosphorus electrophiles on Fmoc-His-OH.
a a Conditions: 0.5 mM Fmoc-His-OH, 5 mM electrophile, 25 mM HEPES pH 8.5, 20% MeCN, 1h; yields were determined by HPLC.
b Reactant readily degenerates and forms precipitate.
incubation at neutral pH (Scheme 2), presumably due to the high acidity of the thiophosphoric acid diester as a leaving group. 45 To prevent this observed hydrolysis, we further replaced the methoxy group with another chloride that eventually hydrolyzes to the corresponding hydroxy congener to introduce a negative charge, akin to stable phosphate diester linkers found in nucleotides. The resulting compound 4, termed thiophosphoro alkyne dichloridate (TPAC), gave higher conversion to product that is resistant to hydrolysis (Scheme 1, Table  S1 ). The thiophosphorus electrophiles 2 and TPAC are superior histidine labeling reagents compared to their oxygen counterparts 3 and 5, presumably owing to the greater stabilization provided by the less electronegative sulfur. The thiophosphodichloridate can be functionalized with other clickable handles such as azide 8 and sterically hindered alkyne 9 that show comparable reactivity. Further characterization using TPAC as a representative thiophosphodichloridate reagents shows optimal histidine labeling at more basic pH values, affording a 60% yield of bioconjugate within twenty minutes at pH 8.5 ( Figure 1b) . The short observed reaction time for TPAC-mediated histidine labeling is primarily controlled by the fast hydrolysis of TPAC itself ( Figure S1 ), which is advantageous since the reaction does not require quenching of residual TPAC to halt its reactivity and the reagent can thus be used in excess. Moreover, the thiophospho-histidine product shows reasonable stability under various conditions including high temperature, acidic, basic, reducing and alkylating environments (Table S1 ). Most importantly, TPAC exhibits high selectivity for histidine, showing negligible reactivity on other nucleophilic amino acids (Figure 1c, Figure S2 ). The results collectively identify TPAC as a promising candidate for chemoselective bioconjugation to histidine. TPAC bioconjugation on model proteins. With these results in hand, we moved on to test TPAC labeling of histidine on intact protein substrates (Figure 1a) . We used ribonuclease A as a model protein and analyzed bioconjugation reactions by mass spectrometry. The TPAC labeling is dose-dependent, generating ca. 45% singly-modified protein and 11% doublymodified protein at pH 8.5 (Figure 2b) . Similar to what was observed in small-molecule amino acid models, the TPACribonuclease A coupling reaction was more effective at slightly basic conditions compared to neutral pH (Figure 2c) . We further performed LC-MS/MS of the digested protein to analyze the site of modification. Similar to other phosphopeptides, the TPAC modification undergoes significant neutral loss in collision-induce dissociation (CID), but the fragment peaks are sufficient for identifying the site of modification ( Figure  S3d −e). We also used electron-transfer dissociation (ETD) on peptides with ambiguous modification sites for supplementary information ( Figure S3c) . Interestingly, the LC-MS/MS of the digested protein indicates that the reaction occurs primarily on H48, a surface-exposed histidine rather than histidines at the catalytic center (H12 and H119). In addition, two other histidine sites, on at the active site (H119) and one that is not (H105), are also modified to less extent, as shown qualitatively by extracted precursor ion chromatogram ( Figure S3a ). The data are also in line with the negligible loss of activity of ribonuclease A after TPAC treatment ( Figure S3b) .
We then demonstrated that the TPAC bioconjugation method is amenable to labeling histidine residues on other proteins, including calmodulin, myoglobin and lysozyme. The yields vary for these proteins (Figure 2d−f) , and the reaction shows excellent histidine selectivity on calmodulin and myoglobin ( Figure S4, S5) . Modest side-reactivity towards lysine is observed on lysozyme, but lysine labeling can be suppressed by lowering the pH to 7.5 to further block the nucleophilicity of the lysine residues by protonation, while increasing TPAC concentrations to compensate the decreased histidine reactivity ( Figure S6 ). TPAC labeling in HeLa lysates also proceeds smoothly as shown by in-gel fluorescence ( Figure S7a) , and more importantly, pretreatments of lysates with competing electrophiles that block cysteine, lysine or serine residues do not affect the observed TPAC signal, suggesting that the reagent does not appreciably react with these competing amino acid residues (Figure S7b-e). Taken together, the results show that TPAC is effective at selectively labeling native histidine residues on proteins.
We then sought to apply this histidine bioconjugation method to install clickable payloads onto proteins. Considering that TPAC converts the slightly basic histidine residue into a rather acidic thiophosphoric acid derivative, we reasoned that the labeled protein can be separated readily from the unreacted protein by its charge difference. Indeed, the separation of the reaction mixture of ribonuclease A and TPAC is effective on a strong cation exchange column buffered at pH 4.2, giving rise to three fractions ( Figure 3a) . The mass spectra of these fractions confirms our hypothesis: unreacted ribonuclease A carries more positive charge and elutes last, the doubly TPAC-modified ribonuclease A protein is less positively charged and elutes first, and the singly TPAC-modified protein elutes between these two fractions (Figure 3b) . After the facile isolation of TPAC-modified reaction products, we further performed copper(I)-catalyzed alkyne-azide cycloaddition (CuAAC) between mono-labeled ribonuclease A and either Cy3-N 3 or desthiobiotin-N 3 payloads for detection and enrichment, respectively ( Figure S8 ). As expected, the obtained protein is uniform with only one payload per protein molecule (Figure 3b ). Collectively, TPAC labeling with subsequent ion exchange chromatography and CuAAC chemistry provides a versatile and robust workflow to create homogenous proteins modified on histidine residues.
TPAC bioconjugation on His-tag for protein delivery. To showcase the potential merits of TPAC bioconjugation chemistry at the cellular level, we turned our attention to selective modification of polyhistidine-tagged proteins (e.g., His-tag). His-tag is a widely used method for purification of proteins by introducing a short polyhistidine peptide fused to the surface exposed portion of the protein of interest for sub-sequent resin capture and separation. We envisioned that this polyhistidine motif would greatly enhance the labeling efficiency of TPAC in a site-specific manner, and we demonstrated this possibility by combining TPAC labeling with further bioconjugation by CuAAC with polyarginine, a cell-penetrating peptide, to create a general method for enabling protein delivery into living cells ( Figure 4a ). We utilized GFP bearing an N-terminal 10×His- tag as a proof-of-concept protein, where TPAC-labeling greatly reduces binding and recognition of His-tag GFP by a Histag antibody, consistent with efficient labeling of TPAC in this His-tag region (Figure 4c ). Indeed, TPAC labeling followed by CuAAC with desthiobiotin-N 3 on His-tag GFP produces a significantly stronger signal compared to GFP without the His-tag on a streptavidin blot (Figure 4b ), further indicating that TPAC selectively reacts with histidine residues on the His-tag rather than other histidine residues on this protein.
Similarly, LC-MS analysis of the digested protein after TPAC treatment only identifies one to three modifications, all of which appear on the His-tag region ( Figure S9 ). With this information in hand, we performed CuAAC between TPAClabeled His-tag GFP and N 3 -(Arg) 9 -OH to introduce cellpenetrating capabilities onto the protein. Indeed, the (Arg) 9 functionalized GFP is now capable of being delivered into HeLa cells as shown by increases in intracellular green fluorescence as observed by confocal microscopy, whereas Histagged GFP without TPAC or N 3 -(Arg) 9 -OH treatment results in no fluorescence signal over dark background (Figure 4d) . Similar results are also observed with an mCherry construct carrying an N-terminus 6×His-tag ( Figure S10 ). Taken together, this line of experiments shows that TPAC can provide covalent, histidine-selective bioconjugation that is functional in living cells.
CONCLUSION
To close, we have reported thiophosphorodichloridates inspired by native histidine phosphorylation processes as reagents for histidine-selective covalent modification of proteins. With TPAC, an alkyne-tagged version of this family of probes, we demonstrated efficient bioconjugation on model proteins with excellent selectivity for histidine over other potentially reactive amino acids. TPAC-labeled proteins are readily purified and can undergo further coupling with bioorthogonal click chemistry to introduce a variety of payloads. In one example to illustrate the utility of this approach, TPAC labeling was applied to introduce polyarginine motifs selectively onto His-tag proteins to endow membrane permeability and enable delivery into living cells. Owing to central importance of histidine residues in enzyme chemistry, this work provides a new type of reagent for probing histidine function in native contexts. Likewise, the efficient labeling of polyhistidine tags can enable versatile protein functionalization for biochemical and protein engineering studies in both fundamental and applied settings. Coupled with recent work from our laboratory on the development of selective methionine bioconjugation reagents that operate by redox-mediated nitrogen group transfer processes inspired by native oxygen atom-transfer oxidations that transform methionine to methionine sulfoxide, 22 mimicking histidine phosphorylation can provide a starting point for developing histidine-selective bioconjugation chemistry. We are currently expanding and applying the toolbox of activity-based sensing reagents in this direction to develop chemoselective probes for other reactive amino acid sites in proteins and proteomes.
Experimental Section
Chemical and protein materials. All commercial reagents were used without further purification. Fmoc-Cys-OH was purchased from Chem-Impex (Wood Dale IL). All other Fmoc-protected amino acids were purchased from Ark Pharm (Arlington Heights IL). 2-(4-((bis ((1-(tert-butyl)-1H-1,2,3 triazol-4-yl)methyl)amino)methyl)-1H -1,2,3-triazol-1-yl)acetic acid (BTTAA) was purchased from Click Chemistry Tools (Scottsdale AZ). Ribonuclease A from bovine pancreas, lyzome from chicken egg white, myoglobin from equine heart and all other chemicals were purchased from Sigma-Aldrich (St. Louis MO). Calmodulin, porcine was purchased from rPeptide (Watkinsville GA). His-tagged GFP was purchased from Sino Biological (Beijing, China). His-tagged mCherry was purchased from Origene (Rockville MD). Enterokinase was purchased from New England Biolabs (Ipswich MA). TEV protease was purchased from QB3 (San Francisco CA). Enzymes were used following the protocols provided by their manufacturer. Reaction between phosphorus electrophiles and amino acids. Fmoc-protected amino acid was dissolved in DMSO (100 mM) and diluted to a final concentration of 0.
Protein labelling with TPAC. Proteins were diluted into 25 mM HEPES, pH 8.5 to a concentration of 20 μM unless otherwise noted. Samples were labelled with 2 mM of TPAC (50x stock in MeCN). The reaction was performed at room temperature for 1 h. Samples were then subject to LC/MS analysis or further click reaction or LC-MS analysis.
Purification of TPAC-labelled ribonuclease A. The reaction mixture of RNase A with TPAC was diluted in 20 mM sodium succinate, pH 4.2 and was loaded onto HiTrap SP HP cation exchange chromatography column (1 mL, GE Healthcare, Chicago IL). The protein was then separated with a linear gradient from 20 mM sodium succinate, pH 4.2 to 25 mM succinate with 1 M NaCl, pH 4.2 at a flow rate of 1.0 mL/min over 40 min. The collected fractions were concentrated and buffer-exchanged into desired buffer for click reaction or LC/MS analysis.
Click reactions on TPAC-labelled proteins. We followed the protocol recommended by M. Finn, et al for click reactions. 46 Namely, protein solution in HEPES or PBS buffer was treated with 1 mM aminoguanidine hydrochloride (100x stock in water), 100 μM CuSO 4 (100x stock in water), 500 μM THPTA or BTTAA (100x stock in water), 100 μM organic azide (100x stock in DMSO or water) and 5 mM sodium ascorbate (100x stock in water). For reaction on his-tagged protein 100 μM NiCl 2 (100x stock in water) was also added. The reaction was mixed thoroughly and placed in the dark at room temperature. After 1 h the reaction was quenched by adding 500 μM EDTA.
For click reaction with Cy3-N 3 , proteins were precipitated with acetone prior to click reaction to remove excess TPAC. The pellet was dissolved in PBS containing 0.1% SDS for click reaction, and precipitated again to remove unreacted dye. The pellet was then dissolved in running buffer and analyzed by SDS-PAGE.
For click reaction on TPAC-labelled, His-tagged proteins, proteins were buffer-exchanged into 25 mM HEPES, pH 7.5 by extensive ultrafiltration (Amnicon 10K, EMD Millipore, Hayward CA) prior to click reaction. After the click reaction, proteins were buffer-exchanged into PBS by extensive ultrafiltration to remove unwanted chemicals.
Cell culture and imaging Cells were grown in the Cell Culture Facility at the University of California, Berkeley. HeLa cells were cultured in DMEM supplemented with 10% FBS and glutamine (2 mM). One day before imaging, cells were passed and plated on eight-well chamber slides (Lab-Tek, Thermo Fisher).
For imaging, cells were grown on 8-well chamber slides (LabTek, Thermo Fisher) to desired confluency, washed with PBS and incubated with 0.1 mg/mL (Arg) 9 -labelled GFP or mCherry in PBS for 15 min at 37 °C. The cells were then washed with PBS and stained with 1 μM Hoechst 33342 for 15 min, washed again and imaged on a Zeiss LSM710 laserscanning microscope with a 63× oil-immersion objective lens. Excitation was provided at 405 for Hoechst 33342, 488 nm for GFP and 543 nm for mCherry.
Synthesis of methyl propargyl thiophosphorochloridate (2). To a flask containing PSCl 3 (2 mL, 20 mmol) cooled in ice/water bath was added dry methanol (2.0 mL, 49 mmol) dropwise. The mixture was stirred for 15 min on ice and excess methanol was distilled under vacuum at the same temperature to give crude methyl thiophosphorodichloridate. Sodium (0.453 g, 19.7 mmol) was dissolved in cooled propargyl alcohol (6.0 mL, 104 mmol) to form an orange, thick solution, which was added dropwise to methyl thiophosphorodichloridate cooled in ice/water bath. The suspension was further stirred for 2 h at room temperature, diluted with CH 2 Cl 2 , filtered and purified by column chromatography (30:1 hexanes/EtOAc) to give product 2 as a colorless oil (2.4 g, 67%). 1 
Synthesis of methyl propargyl thiophosphoramidate (1).
Crude 2 in propargyl alcohol and CH 2 Cl 2 was prepared as described above. Excess ammonia was led through this mixture to form NH 4 Cl as a precipitate. The mixture was filtered, concentrated and purified by column chromatography (2:1 hexanes/EtOAc) to give product 1 as a light yellow oil (2.1 g, 65% overall yield).
1 H NMR (400 MHz, MeOD) δ 4.62 (dd, J = 10.5, 2.5 Hz, 2H), 3.68 (d, J = 13.8 Hz, 3H), 2.94 (t, J = 2.5 Hz, 1H). 13 
Synthesis of propargyl thiophosphorodichloridate (4, TPAC).
To a solution of PSCl 3 (1.0 mL, 9.8 mmol) in CH 2 Cl 2 (10 mL) was added propargyl alcohol (0.57 mL, 9.8 mmol) and K 2 CO 3 (1.36 g, 9.8 mmol). After overnight stirring at room temperature, the mixture was filtered and purified by column chromatography (50:1 hexanes/EtOAc) to give product TPAC as a colorless oil with a pungent smell (1.1 g, 55%) . 1 H NMR (400 MHz, CDCl 3 ) δ 4.94 (dd, J = 15.9, 2.5 Hz, 2H), 2.72 (t, J = 2.5 Hz, 1H). 13 
. Synthesis of propargyl phosphorodichloridate (5). POCl 3 (1.0 mL, 11 mmol) and propargyl alcohol (0.62 mL, 11 mmol) was dissolved in Et 2 O (20 mL) and cooled in dry ice/acetone bath under N 2 . Triethylamine (1.5 mL, 11 mmol) was dissolved in Et 2 O (20 mL) and added dropwise via addition funnel to form a white suspension. The reaction mixture was warmed to room temperature and was furthered stirred at room temperature for 2 h. Trimethylamine hydrochloride was removed by filtration, and the solution was concentrated to give product 5 as a light yellow oil with a pungent smell (1.8 g, 99%). The product was used without further purification. 1 ).
Synthesis of methyl propargyl phosphorochloridate (3).
Crude 5 with trimethylamine hydrochloride in Et 2 O was prepared as described above. The mixture was cooled again in dry ice/acetone bath. Dry methanol (0.43 mL, 11 mmol) and trimethylamine (1.5 mL, 11 mmol) in Et 2 O (20 mL) was added dropwise via addition funnel. The slurry was further stirred at room temperature for 3 h, filtered and concentrated to give product 3 as light yellow oil with a pungent smell (1.7 g, 93%) . 1 
. Synthesis of N-propargyl thiophosphoramidic dichloride (6). To a solution of PSCl 3 (0.30 mL, 2.9 mmol) in CH 2 Cl 2 (5 mL) was added propargyl amine (0.19 mL, 2.9 mmol) and K 2 CO 3 (0.41 g, 2.9 mmol). After 2 h stirring at room temperature, the mixture was filtered and purified by column chromatography (30:1 hexanes/EtOAc) to give product 6 as a yellow oil with a pungent smell (0.25 g, 49%).
1 H NMR (400 MHz, Acetone) δ 4.09 (dd, J = 20.7, 2.5 Hz, 2H), 2.89 (t, J = 2.5 Hz, 1H). 13 
Synthesis of propargyl dithiophosphorodichloridate (7).
S-propargyl thioacetate (0.35 mg, 3.1 mmol) was stirred with NaOH (0.16 g, 4.0 mmol) in MeOH (10 mL) under N 2 for 30 min. The mixture was then diluted with CH 2 Cl 2 (30 mL), washed with H 2 O (×4) and dried (Na 2 SO 4 ). To this solution was added PSCl 3 (0.37 mL, 3.7 mmol) and K 2 CO 3 (0.51g, 3.7 mmol) and the mixture was stirred overnight. The mixture was filtered and purified by column chromatography (100:1 hexanes/EtOAc) to give product 7 as a light yellow oil, which degenerates into a solid mixture soon after concentration.
1 H NMR (600 MHz, CDCl 3 ) δ 3.75 (dd, J = 15.6, 2.7 Hz, 2H), 2.35 (t, J = 2.7 Hz, 1H).
Synthesis of 2-azidoethyl thiophosphorodichloridate 8. 2-Azidoethanol (0.43 g, 4.9 mmol) was dissolved in dry THF (15 mL) under N 2 and cooled in dry ice/acetone bath. To this solution was added dropwise nBuLi (2.0 mL, 2.5 M in hexanes) and stirred for 20 min at room temperature to form the lithium salt. To another flask cooled in dry ice/acetone bath was added THF (15 mL) and PSCl 3 (1.0 mL, 4.9 mmol) under N 2 . The lithium salt solution was then added dropwise at this temperature and the mixture was then stirred for 1h at room temperature. The mixture was concentrated, diluted in CH 2 Cl 2 , filtered to remove lithium chloride and purified by column chromatography (50:1 hexanes/EtOAc) to give product 8 as a light yellow oil with a pungent smell (0.60 g, 56%). 
. Synthesis of (±)-3-butyn-2-yl thiophosphorodichloridate (9). (±)-3-Butyn-2-ol (0.77 mL, 9.8 mmol) was dissolved in dry THF (10 mL) under N 2 and cooled in dry ice/acetone bath. To this solution was added dropwise nBuLi (3.9 mL, 2.5 M in hexanes) and stirred for 20 min at room temperature to form the lithium salt. To another flask cooled in dry ice/acetone bath was added THF (20 mL) and PSCl 3 (1.0 mL, 9.8 mmol) under N 2 . The lithium salt solution was then added dropwise at this temperature and the mixture was then stirred for 3h at room temperature. The mixture was concentrated, diluted in CH 2 Cl 2 , filtered to remove lithium chloride and purified by column chromatography (100:1 hexanes/EtOAc) to give product 9 as a colorless oil with a pungent smell (0.53 g, 26%). 1 
